Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface
about
The G protein-coupled receptor heterodimer network (GPCR-HetNet) and its hub componentsMembrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors.Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level.The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic DrugsTargeting the dopamine D3 receptor: an overview of drug design strategies.Methods used to study the oligomeric structure of G-protein-coupled receptors.Distinct Agonist Regulation of Muscarinic Acetylcholine M2-M3 Heteromers and Their Corresponding Homomers.The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerizationReduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevanceDopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia.Glioblastoma treatment using perphenazine to block the subventricular zone's tumor trophic functions.Biophysical Detection of Diversity and Bias in GPCR Function.Insights into the structural biology of G-protein coupled receptors impacts drug design for central nervous system neurodegenerative processes.Structure and function of G protein-coupled receptor oligomers: implications for drug discovery.Analysis of Human Dopamine D3 Receptor Quaternary Structure.A Broad G Protein-Coupled Receptor Internalization Assay that Combines SNAP-Tag Labeling, Diffusion-Enhanced Resonance Energy Transfer, and a Highly Emissive Terbium Cryptate.A Molecular Basis for Selective Antagonist Destabilization of Dopamine D3 Receptor Quaternary Organization.
P2860
Q24564171-7E76A1AD-3ABA-44C3-907C-9861FBB798AAQ27300848-F1F287E9-EA11-44A4-9F3D-E217669716A0Q27348715-8CF76B83-9D9A-4EB6-A092-F4EC06373593Q33707895-27441F6F-1E87-4CC4-97DB-707A3A920C31Q34524556-B93155AF-E97A-4422-B554-B2A70667E4A4Q34548734-7521BFC6-D832-4DF2-AB37-9D9A0B8107FAQ35860873-8C799157-2040-4334-9AB9-B686077F51C8Q36935273-EF9DC051-BF06-4946-9F52-7031C078C9C8Q37252065-169AB321-A2A6-43F8-8788-BE0B02D805BBQ37379456-0EB6104C-9D04-40FC-9A1F-6593060CD0ADQ38057963-D4C8D5B7-E8AA-4E22-A80E-72013518FCE3Q38163420-887DFDBC-65E6-4798-B169-41A04B9B5156Q38196401-2500DF49-D84C-4BE2-88FF-2DAF955D344DQ38247995-12CB4100-483E-49DB-9312-44C0298AA8F9Q38292961-89FB3424-A1C3-4428-B488-7E527B9B4D30Q40990314-543BDD67-D47D-4A2A-BB73-4102EF244F49Q41843794-68A5D0BC-9D61-4C01-8A11-98AEB434C2EFQ42257101-19DE1A2F-449A-4F1E-9109-422474FD8AA9
P2860
Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Functional homomers and hetero ...... s co-exist at the cell surface
@ast
Functional homomers and hetero ...... s co-exist at the cell surface
@en
type
label
Functional homomers and hetero ...... s co-exist at the cell surface
@ast
Functional homomers and hetero ...... s co-exist at the cell surface
@en
prefLabel
Functional homomers and hetero ...... s co-exist at the cell surface
@ast
Functional homomers and hetero ...... s co-exist at the cell surface
@en
P2093
P2860
P356
P1476
Functional homomers and hetero ...... s co-exist at the cell surface
@en
P2093
Chantevy Pou
Clotilde Mannoury la Cour
Graeme Milligan
Mark J Millan
P2860
P304
P356
10.1074/JBC.M111.326678
P407
P577
2012-01-30T00:00:00Z